Fatemeh Rafii
Division of Microbiology
National Center for Toxicological Research
U.S. Food and Drug Administration
3900 NCTR Road
USA
Name/email consistency: high
- Comparison of the metabolic activities of four wild-type Clostridium perfringens strains with their gatifloxacin-selected resistant mutants. Rafii, F., Park, M., Gamboa da Costa, G., Camacho, L. Arch. Microbiol. (2009)
- Characterization of an ATP-binding cassette from Clostridium perfringens with homology to an ABC transporter from Clostridium hathewayi. Rafii, F., Park, M., Carman, R.J. Anaerobe (2009)
- Detection and characterization of an ABC transporter in Clostridium hathewayi. Rafii, F., Park, M. Arch. Microbiol. (2008)
- Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens. Rafii, F., Park, M., Bryant, A.E., Johnson, S.J., Wagner, R.D. Antimicrob. Agents Chemother. (2008)
- Metabolism of daidzein by fecal bacteria in rats. Rafii, F., Jackson, L.D., Ross, I., Heinze, T.M., Lewis, S.M., Aidoo, A., Lyn-Cook, L., Manjanatha, M. Comp. Med. (2007)
- Substitutions of amino acids in alpha-helix-4 of gyrase A confer fluoroquinolone resistance on Clostridium perfringens. Rafii, F., Park, M. Arch. Microbiol. (2007)
- Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones. Rafii, F., Park, M., Novak, J.S. Antimicrob. Agents Chemother. (2005)